US › Healthcare

Stevanato Group SpA (STVN)

US · Healthcare · Medical Instruments & Supplies

$19.65-4.57%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$273.6M
Revenue YoY
+6.6%
Net profit
$28.0M
Profit YoY
+5.7%
EPS
$0.13
EPS estimate
$0.12
Net margin
10.2%

EPS came in at 0.13 against a street estimate of 0.12 — a beat of 8.3%.

Key statistics

Market cap
$5.42B
P/E
33.6
Forward P/E
33.1
P/B
3.09
Book value
$6.39
EPS (TTM)
$0.59
52-week high
$27.90
52-week low
$12.84
50-day MA
$18.56
200-day MA
$18.76
Beta
0.78

Analyst view

Analysts rate Stevanato Group SpA a buy (8 buy, 3 hold, 0 sell out of 11) with an average price target of $24.45.

Shareholding

Insiders
1.65%
Institutions
96.15%

Largest institutional holders

FundStake
Conestoga Capital Advisors, LLC2.57%
Neuberger Berman Group LLC1.64%
TimesSquare Capital Management, LLC1.28%
T. Rowe Price Investment Management,Inc.1.18%
BAMCO Inc0.92%
Artisan Partners Limited Partnership0.84%
Morgan Stanley - Brokerage Accounts0.48%
Ranger Investment Management LP0.47%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Stevanato Group SpA — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.